AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32561505 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal training (n=38)
Number of subjects: 107
Study 32745639 — intervention group
Group type: EXPERIMENTAL
Intervention: Gluten challenge (PGC)
Number of subjects: 21
Study 32745639 — intervention group
Group type: COMPARATOR
Intervention: Gluten-free diet (GFD)
Number of subjects: 21
Study 32745639 — intervention group
Group type: EXPERIMENTAL
Intervention: Regression models using four gene transcripts
Number of subjects: 21
Study 32100502 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupoint catgut embedding therapy combined with rehabilitation training
Number of subjects: 60
Study 32100502 — intervention group
Group type: COMPARATOR
Intervention: Routine ASD rehabilitation training
Number of subjects: 60
Study 34921121 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment arm (specific treatment not detailed)
Number of subjects: 433
Study 34921121 — intervention group
Group type: COMPARATOR
Intervention: Placebo arm
Number of subjects: 433
Study 32187128 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological nursing intervention in addition to routine nursing care
Number of subjects: 286
Study 32187128 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing care
Number of subjects: 286
Study 32985652 — intervention group
Group type: EXPERIMENTAL
Intervention: EG-1962 (600 mg nimodipine administered into the basal cisterns)
Number of subjects: 6
Study 32985652 — intervention group
Group type: COMPARATOR
Intervention: Oral nimodipine
Number of subjects: 6
Study 32985652 — intervention group
Group type: EXPERIMENTAL
Intervention: EG-1962
Number of subjects: 6
Study 32985652 — intervention group
Group type: EXPERIMENTAL
Intervention: EG-1962 and Oral nimodipine
Number of subjects: 6
Study 33223426 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg GSK958108
Number of subjects: 35
Study 33223426 — intervention group
Group type: EXPERIMENTAL
Intervention: 7 mg GSK958108
Number of subjects: 35
Study 33223426 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 32004995 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic footprints
Number of subjects: 461
Study 32004995 — intervention group
Group type: COMPARATOR
Intervention: Static footprints
Number of subjects: 461
Study 33865691 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-release buprenorphine (XR-B), n = 335
Number of subjects: 1005
Study 33865691 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-release naltrexone (XR-NTX), n = 335
Number of subjects: 1005
Study 33865691 — intervention group
Group type: COMPARATOR
Intervention: Enhanced treatment as usual arm, n = 335
Number of subjects: 1005
Study 32877576 — intervention group
Group type: EXPERIMENTAL
Intervention: rSARS-CoV-2 vaccine with Matrix-M1 adjuvant
Number of subjects: 131
Study 32877576 — intervention group
Group type: EXPERIMENTAL
Intervention: rSARS-CoV-2 vaccine without Matrix-M1 adjuvant
Number of subjects: 131
Study 32877576 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 131
Study 35979596 — intervention group
Group type: COMPARATOR
Intervention: Conventional fluoroscopic guidance (CF group)
Number of subjects: 123
Study 35979596 — intervention group
Group type: EXPERIMENTAL
Intervention: EnSite Precision mapping system (zeroFluoro, ZF group)
Number of subjects: 123
Study 35445990 — intervention group
Group type: EXPERIMENTAL
Intervention: Imrecoxib
Number of subjects: 126
Study 32661940 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonconvulsive electrotherapy (NET)
Number of subjects: 20
Study 35403213 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of fresh cow's milk (ED05)
Number of subjects: 60
Study 35403213 — intervention group
Group type: COMPARATOR
Intervention: Routine care (control)
Number of subjects: 60
Study 35032128 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum leptin concentration in individuals with BMI > 40 kg/m2
Number of subjects: 109
Study 35032128 — intervention group
Group type: COMPARATOR
Intervention: Serum leptin concentration in overweight individuals
Number of subjects: 109
Study 35032128 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum leptin levels in women
Number of subjects: 109
Study 35032128 — intervention group
Group type: COMPARATOR
Intervention: Serum leptin levels in men
Number of subjects: 109
Study 35032128 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of leptin level with insulin
Number of subjects: 109
Study 35032128 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of leptin level with HOMA-IR
Number of subjects: 109
Study 35032128 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of leptin level with BMI
Number of subjects: 109
Study 32421440 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally Invasive Esophagectomy (MIE)
Number of subjects: 4720
Study 32421440 — intervention group
Group type: COMPARATOR
Intervention: Inclusion in the TIME trial
Number of subjects: 4720
Study 34568974 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-periodized group (NG)
Number of subjects: 69
Study 34568974 — intervention group
Group type: EXPERIMENTAL
Intervention: Linear periodized group (PG)
Number of subjects: 69
Study 34568974 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 69
Study 32706977 — intervention group
Group type: EXPERIMENTAL
Intervention: CT radiomics prediction model
Number of subjects: 119
Study 32706977 — intervention group
Group type: COMPARATOR
Intervention: Conventional contrast-enhanced CT (CECT)
Number of subjects: 119
Study 32975823 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermal suit with FAW unit set to 38°C
Number of subjects: 40
Study 32975823 — intervention group
Group type: COMPARATOR
Intervention: Hospital clothes with lower body blanket set to 38°C and warming mattress set to 37°C
Number of subjects: 40
Study 32975823 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermal suit with FAW unit
Number of subjects: 40
Study 32975823 — intervention group
Group type: COMPARATOR
Intervention: Hospital clothes with lower body blanket and warming mattress
Number of subjects: 40
Study 33069667 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental Coaching (SG; n=9)
Number of subjects: 18
Study 33069667 — intervention group
Group type: COMPARATOR
Intervention: Routine follow-up (CG; n=9)
Number of subjects: 18
Study 36099876 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-aminolevulinic acid (5-ALA) with sodium ferrous citrate (SFC)
Number of subjects: 74
Study 36099876 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study 34852693 — intervention group
Group type: EXPERIMENTAL
Intervention: Body mass-based resistance training (bmRT)
Number of subjects: 46
Study 34852693 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 46
Study 36331328 — intervention group
Group type: EXPERIMENTAL
Intervention: Camrelizumab plus chemotherapy
Number of subjects: 144
Study 36331328 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 144
Study 34006921 — intervention group
Group type: EXPERIMENTAL
Intervention: Tesamorelin
Number of subjects: 0
Study 32620370 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D‐printed ear splint
Number of subjects: 40
Study 32620370 — intervention group
Group type: COMPARATOR
Intervention: Conventional thermoplastic ear splint
Number of subjects: 40
Study 36206152 — intervention group
Group type: EXPERIMENTAL
Intervention: Anthocyanin intake (ATH group) - daily intake of açaí‐juçara 200 g (anthocyanins 293.6 mg) for 12 weeks.
Number of subjects: 55
Study 36206152 — intervention group
Group type: COMPARATOR
Intervention: Non-anthocyanin intake (N-ATH group) - 12-week individualized diet plan with 20% reduction in total energy intake.
Number of subjects: 55
Study 36206152 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (ATH and N-ATH)
Number of subjects: 55
Study 33713385 — intervention group
Group type: EXPERIMENTAL
Intervention: World Health Organization growth standards
Number of subjects: 683
Study 33713385 — intervention group
Group type: COMPARATOR
Intervention: China growth charts
Number of subjects: 683
Study 32245644 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based educational intervention (45-minute lecture on HPV and HPV vaccine knowledge)
Number of subjects: 0
Study 32245644 — intervention group
Group type: COMPARATOR
Intervention: Control classes (no educational intervention)
Number of subjects: 0
Study 34907617 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 µg Clobetasol patch (Rivelin® ‐CLO), twice daily, for 4 weeks
Number of subjects: 138
Study 34907617 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 µg Clobetasol patch (Rivelin® ‐CLO)
Number of subjects: 138
Study 34907617 — intervention group
Group type: COMPARATOR
Intervention: Placebo (nonmedicated)
Number of subjects: 138
Study 32577847 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative ultrasound
Number of subjects: 6
Study 32577847 — intervention group
Group type: COMPARATOR
Intervention: Macroscopic evaluation by the surgeon
Number of subjects: 6
Study 35176724 — intervention group
Group type: EXPERIMENTAL
Intervention: Wii Fit training (n = 25)
Number of subjects: 50
Study 35176724 — intervention group
Group type: COMPARATOR
Intervention: Usual school program (n = 25)
Number of subjects: 50
Study 32878959 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy programme comprising thoracic and shoulder girdle exercises
Number of subjects: 19
Study 32878959 — intervention group
Group type: COMPARATOR
Intervention: Normal care (control group)
Number of subjects: 19
Study 33150385 — intervention group
Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass (RYGB)
Number of subjects: 92
Study 33150385 — intervention group
Group type: COMPARATOR
Intervention: Sleeve gastrectomy (SG)
Number of subjects: 92
Study 32110882 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (0.15 mg/kg (LBM))
Number of subjects: 32
Study 32110882 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 32
Study 33483508 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral immunotherapy
Number of subjects: 0
Study 33483508 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32471492 — intervention group
Group type: EXPERIMENTAL
Intervention: Administration of Patient Health Questionnaire (PHQ‐9) as a PROM within 2 weeks of diagnosis and at follow‐up 4 weeks later. General practitioners trained in interpreting scores and providing feedback.
Number of subjects: 676
Study 36394384 — intervention group
Group type: EXPERIMENTAL
Intervention: Ertugliflozin
Number of subjects: 8246
Study 36394384 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8246
Study 34628740 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep needling at Xiaguan (ST 7) with round sharp needle combined with plum-blossom needle
Number of subjects: 60
Study 34628740 — intervention group
Group type: COMPARATOR
Intervention: Conventional acupuncture
Number of subjects: 60
Study 36014800 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-Inflammatory Diet (AID)
Number of subjects: 53
Study 36014800 — intervention group
Group type: COMPARATOR
Intervention: Canada’s Food Guide (CFG)
Number of subjects: 53
Study 36173391 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 8
Study 36173391 — intervention group
Group type: COMPARATOR
Intervention: Strengthening exercise
Number of subjects: 8
Study 34159451 — intervention group
Group type: EXPERIMENTAL
Intervention: Extremely Randomized Trees (ERT) model
Number of subjects: 0
Study 34159451 — intervention group
Group type: COMPARATOR
Intervention: Multivariate Adaptive Regression Splines (MARS) model
Number of subjects: 0
Study 34159451 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors controlling DEF identified by ERT model
Number of subjects: 0
Study 34159451 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors affecting IDEF identified by ERT model
Number of subjects: 0
Study 32928387 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrophobic SERS substrate prepared by spin-coating lubricating liquid onto commercial paper.
Number of subjects: 0
Study 32928387 — intervention group
Group type: COMPARATOR
Intervention: Hydrophobic SERS substrate
Number of subjects: 0
Study 35972742 — intervention group
Group type: EXPERIMENTAL
Intervention: Commercial weight management program
Number of subjects: 373
Study 35972742 — intervention group
Group type: COMPARATOR
Intervention: Do-It-Yourself (DIY) approach
Number of subjects: 373
Study 32526916 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibialis anterior taping
Number of subjects: 20
Study 32526916 — intervention group
Group type: EXPERIMENTAL
Intervention: Calf taping
Number of subjects: 20
Study 32526916 — intervention group
Group type: COMPARATOR
Intervention: Nontaping condition
Number of subjects: 20
Study 34982321 — intervention group
Group type: EXPERIMENTAL
Intervention: Information film about Oncotype DX
Number of subjects: 120
Study 34982321 — intervention group
Group type: COMPARATOR
Intervention: Information leaflet about Oncotype DX
Number of subjects: 120
Study 34982321 — intervention group
Group type: EXPERIMENTAL
Intervention: Information film about Prosigna
Number of subjects: 120
Study 34982321 — intervention group
Group type: COMPARATOR
Intervention: Information leaflet about Prosigna
Number of subjects: 120
Study 34982321 — intervention group
Group type: EXPERIMENTAL
Intervention: Reading leaflets first, then viewing films
Number of subjects: 120
Study 34982321 — intervention group
Group type: COMPARATOR
Intervention: Viewing films first, then reading leaflets
Number of subjects: 120
Study 34982321 — intervention group
Group type: EXPERIMENTAL
Intervention: Preference for films
Number of subjects: 120
Study 33421682 — intervention group
Group type: EXPERIMENTAL
Intervention: TLT-based debriefing protocol
Number of subjects: 56
Study 33421682 — intervention group
Group type: COMPARATOR
Intervention: Control group (gather-analyze-summarize-based debriefing)
Number of subjects: 56
Study 35553804 — intervention group
Group type: EXPERIMENTAL
Intervention: CBD (50mg/day with 175mg of MCT)
Number of subjects: 14
Study 35553804 — intervention group
Group type: COMPARATOR
Intervention: Placebo (coconut derived MCT; 225mg/day)
Number of subjects: 14
Study 32061417 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio taping (Kinesio Tex)
Number of subjects: 34
Study 32061417 — intervention group
Group type: COMPARATOR
Intervention: Control group (no taping)
Number of subjects: 34
Study 32061417 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio taping
Number of subjects: 34
Study 34958456 — intervention group
Group type: EXPERIMENTAL
Intervention: Reminder group (N=26)
Number of subjects: 81
Study 34958456 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-reminder group (N=28)
Number of subjects: 81
Study 34958456 — intervention group
Group type: COMPARATOR
Intervention: Control group (N=27)
Number of subjects: 81
Study 32441845 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirius minimally invasive bone reduction handle system (SMH)
Number of subjects: 8
Study 32441845 — intervention group
Group type: COMPARATOR
Intervention: Traditional Kern forceps only (KO)
Number of subjects: 8
Study 35909461 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorzolamide 2% eye drops solution (Rompharm Company SRL)
Number of subjects: 32
Study 35909461 — intervention group
Group type: COMPARATOR
Intervention: Trusopt® eye drops solution
Number of subjects: 32
Study 33249909 — intervention group
Group type: EXPERIMENTAL
Intervention: Collared femoral stem (n = 23)
Number of subjects: 49
Study 33249909 — intervention group
Group type: COMPARATOR
Intervention: Collarless femoral stem (n = 26)
Number of subjects: 49
Study 33387930 — intervention group
Group type: EXPERIMENTAL
Intervention: EMS treatments
Number of subjects: 342
Study 33387930 — intervention group
Group type: COMPARATOR
Intervention: Comparison with published treatment time data from other EMS systems
Number of subjects: 342
Study 32001832 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant endocrine therapy (NET) with anastrozole and fulvestrant
Number of subjects: 236
Study 32001832 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant endocrine therapy (NET)
Number of subjects: 236
Study 34154898 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality (VR) training in addition to passive ROM and stretch exercises
Number of subjects: 22
Study 34154898 — intervention group
Group type: COMPARATOR
Intervention: Passive ROM and stretch exercises (Control)
Number of subjects: 22
Study 33245708 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy (listening to music once a day)
Number of subjects: 126
Study 33245708 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy (listening to music twice a day)
Number of subjects: 126
Study 33245708 — intervention group
Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 126
Study 35469036 — intervention group
Group type: EXPERIMENTAL
Intervention: LIFT + BM-MNC injection
Number of subjects: 70
Study 35469036 — intervention group
Group type: COMPARATOR
Intervention: LIFT alone
Number of subjects: 70
Study 34673954 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% HNa + 1% Gln
Number of subjects: 60
Study 34673954 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% HNa + 1% Gln
Number of subjects: 60
Study 34673954 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% HNa + 1% Gln
Number of subjects: 60
Study 34673954 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% HNa + 1% Gln (Exp. 2)
Number of subjects: 60
Study 34673954 — intervention group
Group type: COMPARATOR
Intervention: Basal diet (Control)
Number of subjects: 60
Study 34253600 — intervention group
Group type: EXPERIMENTAL
Intervention: Community monitoring of the forest
Number of subjects: 110
Study 32382784 — intervention group
Group type: EXPERIMENTAL
Intervention: SNPs (rs938112, rs2987902) in genes LSMAP and ABL1
Number of subjects: 356
Study 35710450 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced Care at Home (ACH)
Number of subjects: 360
Study 35710450 — intervention group
Group type: COMPARATOR
Intervention: Traditional inpatient care
Number of subjects: 360
Study 35710450 — intervention group
Group type: EXPERIMENTAL
Intervention: ACH
Number of subjects: 360
Study 33539980 — intervention group
Group type: EXPERIMENTAL
Intervention: Hip arthroscopy intervention (specific details not provided)
Number of subjects: 8
Study 32097825 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive interpretation training
Number of subjects: 71
Study 32097825 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative interpretation training
Number of subjects: 71
Study 32097825 — intervention group
Group type: COMPARATOR
Intervention: Cognitive load during training
Number of subjects: 71
Study 32097825 — intervention group
Group type: COMPARATOR
Intervention: Control group (no cognitive load)
Number of subjects: 71
Study 36123681 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete vaccination with Gam-COVID-Vac (14 days or more after the second dose)
Number of subjects: 13893
Study 34322891 — intervention group
Group type: EXPERIMENTAL
Intervention: Pocket ultrasound device (PUD)
Number of subjects: 86
Study 34322891 — intervention group
Group type: COMPARATOR
Intervention: Conventional ultrasound device (CUD)
Number of subjects: 86
Study 33605177 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional IC training program
Number of subjects: 42
Study 33605177 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral IC training program
Number of subjects: 42
Study 33605177 — intervention group
Group type: COMPARATOR
Intervention: Waitlisted control
Number of subjects: 42
Study 33683300 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of conservative treatments (education on self-management and ergonomic principles, base-of-thumb splint, hand exercises, diclofenac sodium 1% gel)
Number of subjects: 204
Study 33683300 — intervention group
Group type: COMPARATOR
Intervention: Education on self-management and ergonomic principles alone (comparator group)
Number of subjects: 204
Study 32757131 — intervention group
Group type: EXPERIMENTAL
Intervention: Index-based approach to assess flood disaster resilience
Number of subjects: 20
Study 32757131 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical conditions, human resources, institutional issues, and external relationships
Number of subjects: 20
Study 34864943 — intervention group
Group type: EXPERIMENTAL
Intervention: Maribavir 400 mg twice daily
Number of subjects: 352
Study 34864943 — intervention group
Group type: COMPARATOR
Intervention: Investigator-assigned therapy (IAT; valganciclovir/ganciclovir, foscarnet, or cidofovir)
Number of subjects: 352
Study 34864943 — intervention group
Group type: COMPARATOR
Intervention: Foscarnet
Number of subjects: 352
Study 34864943 — intervention group
Group type: COMPARATOR
Intervention: Valganciclovir/ganciclovir
Number of subjects: 352
Study 33546752 — intervention group
Group type: EXPERIMENTAL
Intervention: ActionADE intervention transmitting information to PharmaNet
Number of subjects: 3600
Study 33546752 — intervention group
Group type: COMPARATOR
Intervention: Control arm with ActionADE retaining information in the local record
Number of subjects: 3600
Study 35809742 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine infusion via TAP catheter
Number of subjects: 49
Study 35809742 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study 33748067 — intervention group
Group type: EXPERIMENTAL
Intervention: Health literacy assessment using the HLS-EU-Q16
Number of subjects: 322
Study 33748067 — intervention group
Group type: EXPERIMENTAL
Intervention: Health literacy assessment
Number of subjects: 322
Study 32825845 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity intervention (group sessions, telephone consultations, behavior design, hotline, buddy-matching)
Number of subjects: 600
Study 32825845 — intervention group
Group type: COMPARATOR
Intervention: Low-intensity intervention (standard treatment, guideline-based municipal smoking cessation program)
Number of subjects: 600
Study 35549926 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased disgust sensitivity to pathogen stimuli
Number of subjects: 271
Study 35549926 — intervention group
Group type: EXPERIMENTAL
Intervention: Dangerousness attributions in the description of SMI
Number of subjects: 271
Study 33115322 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-selected resistance training (SSRT)
Number of subjects: 32
Study 33115322 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 32
Study 32402832 — intervention group
Group type: EXPERIMENTAL
Intervention: NOSE group (n=122)
Number of subjects: 276
Study 32402832 — intervention group
Group type: COMPARATOR
Intervention: non-NOSE group (n=119)
Number of subjects: 276